Received: 25 October 2019
Accepted: 31 January 2020
First Online: 23 March 2020
Ethics approval and consent to participate
: The study was approved by the Medical Ethical Committee of the Erasmus Medical Center (reference number: MEC-2017-1085).
: Written informed consent was obtained from all the patients.
: T. Brabander is part of the advisory board of AAA/Novartis and receives speaker fees of AAA/Novartis and PrimeOncology. The other authors declare that they have no competing interests.